This site is intended for healthcare professionals

Results of phase III trial of Olumiant + Veklury in COVID-19 published in NEJM.- Eli Lilly and Incyte

Read time: 1 mins
Last updated:13th Dec 2020
Published:13th Dec 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest